160 related articles for article (PubMed ID: 25411894)
21. Expression profiles of long noncoding RNAs and messenger RNAs in the border zone of myocardial infarction in rats.
Meng Q; Sun Z; Gu H; Luo J; Wang J; Wang C; Han S
Cell Mol Biol Lett; 2019; 24():63. PubMed ID: 31827539
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive analysis of aberrantly expressed long non‑coding RNAs, microRNAs, and mRNAs associated with the competitive endogenous RNA network in cervical cancer.
Chen P; Zhang W; Chen Y; Zheng X; Yang D
Mol Med Rep; 2020 Jul; 22(1):405-415. PubMed ID: 32377727
[TBL] [Abstract][Full Text] [Related]
23. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
[TBL] [Abstract][Full Text] [Related]
24. Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study.
Soon PS; Provan PJ; Kim E; Pathmanathan N; Graham D; Clarke CL; Balleine RL
Clin Exp Metastasis; 2018 Feb; 35(1-2):3-13. PubMed ID: 29214365
[TBL] [Abstract][Full Text] [Related]
25. Identification of differentially expressed lncRNAs and mRNAs in luminal-B breast cancer by RNA-sequencing.
Yuan CL; Jiang XM; Yi Y; E JF; Zhang ND; Luo X; Zou N; Wei W; Liu YY
BMC Cancer; 2019 Dec; 19(1):1171. PubMed ID: 31795964
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
[TBL] [Abstract][Full Text] [Related]
27. Profile and validation of dysregulated long non‑coding RNAs and mRNAs in ovarian cancer.
Lu YM; Wang Y; Liu SQ; Zhou MY; Guo YR
Oncol Rep; 2018 Nov; 40(5):2964-2976. PubMed ID: 30132558
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
29. Gene expression profiling of ductal carcinomas in situ and invasive breast tumors.
Seth A; Kitching R; Landberg G; Xu J; Zubovits J; Burger AM
Anticancer Res; 2003; 23(3A):2043-51. PubMed ID: 12894577
[TBL] [Abstract][Full Text] [Related]
30. Promoter hypermethylation of ARID1A gene is responsible for its low mRNA expression in many invasive breast cancers.
Zhang X; Sun Q; Shan M; Niu M; Liu T; Xia B; Liang X; Wei W; Sun S; Zhang Y; Liu XS; Song Q; Yang Y; Ma Y; Liu Y; Yang L; Ren Y; Zhang G; Pang D
PLoS One; 2013; 8(1):e53931. PubMed ID: 23349767
[TBL] [Abstract][Full Text] [Related]
31. Genome-Wide Analysis of Long Noncoding RNA Expression Profiles in Human Xuanwei Lung Cancer.
Li Q; Wu C; Song G; Zhang H; Shan B; Duan Y; Wang Y
Clin Lab; 2015; 61(10):1515-23. PubMed ID: 26642714
[TBL] [Abstract][Full Text] [Related]
32. Genome-Wide Analysis Identified a Number of Dysregulated Long Noncoding RNA (lncRNA) in Human Pancreatic Ductal Adenocarcinoma.
Hao S; Yao L; Huang J; He H; Yang F; Di Y; Jin C; Fu D
Technol Cancer Res Treat; 2018 Jan; 17():1533034617748429. PubMed ID: 29343207
[TBL] [Abstract][Full Text] [Related]
33. The role of long noncoding RNAs in patients with Luminal A invasive breast ductal carcinoma.
Eshghifar N; Rouhollah F; Barikrow N; Pouresmaeili F; Taheri M
Pathol Res Pract; 2021 Nov; 227():153645. PubMed ID: 34678601
[TBL] [Abstract][Full Text] [Related]
34. Transcriptome sequencing profiles reveal lncRNAs may involve in breast cancer (ER/PR positive type) by interaction with RAS associated genes.
Jia Y; Shi L; Yun F; Liu X; Chen Y; Wang M; Chen C; Ren Y; Bao Y; Wang L
Pathol Res Pract; 2019 Jun; 215(6):152405. PubMed ID: 30981459
[TBL] [Abstract][Full Text] [Related]
35. Identification and regulation pattern analysis of long noncoding RNAs in meibomian gland carcinoma.
Song X; Fan J; Jia R; Zhou Y; Ge S; Zhang G; Wang H; Fan X
Epigenomics; 2019 Feb; 11(4):381-400. PubMed ID: 30526034
[TBL] [Abstract][Full Text] [Related]
36. Orchestrating a biomarker panel with lncRNAs and mRNAs for predicting survival in pancreatic ductal adenocarcinoma.
Wu Y; Wei J; Ming Y; Chen Z; Yu J; Mao R; Chen H; Zhou G; Fan Y
J Cell Biochem; 2018 Sep; 119(9):7696-7706. PubMed ID: 29923223
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNAs and their targets as potential biomarkers in breast cancer.
Khalid M; Paracha RZ; Nisar M; Malik S; Tariq S; Arshad I; Siddiqa A; Hussain Z; Ahmad J; Ali A
IET Syst Biol; 2021 Jul; 15(5):137-147. PubMed ID: 33991433
[TBL] [Abstract][Full Text] [Related]
38. Analysis of LncRNA-mRNA Co-Expression Profiles in Patients With Polycystic Ovary Syndrome: A Pilot Study.
Sun X; Liu Y; Gao X; Du M; Gao M; Zhong X; Wei X
Front Immunol; 2021; 12():669819. PubMed ID: 33936113
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA Expression in Laser Micro-dissected Breast Cancer Tissue Samples - a Pilot Study.
Seclaman E; Narita D; Anghel A; Cireap N; Ilina R; Sirbu IO; Marian C
Pathol Oncol Res; 2019 Jan; 25(1):233-239. PubMed ID: 29081035
[TBL] [Abstract][Full Text] [Related]
40. Gene microarray analysis of lncRNA and mRNA expression profiles in patients with high‑grade ovarian serous cancer.
Lou Y; Jiang H; Cui Z; Wang X; Wang L; Han Y
Int J Mol Med; 2018 Jul; 42(1):91-104. PubMed ID: 29577163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
